Answers are grounded in this paper and cite their sources.
A growing body of evidence suggests that NSAIDs may be beneficial in the treatment of age-related macular degeneration, diabetic retinopathy, and ocular tumors. Recent studies from our group and other authors have shown that the vitreous levels of NSAID exceed the median inhibitory concentration, which can significantly decrease vitreous PGE2 levels.
No takes yet. Share an insight, caveat, or question.
Semeraro et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: